Chemed Corp (NYSE:CHE)
$ 575.24 1.11 (0.19%) Market Cap: 8.68 Bil Enterprise Value: 8.51 Bil PE Ratio: 30.96 PB Ratio: 7.33 GF Score: 96/100

Chemed Corp at Jefferies Healthcare Conference Transcript

Jun 05, 2019 / 03:00PM GMT
Release Date Price: $340.18 (+1.27%)
Brian Gil Tanquilut
Jefferies LLC, Research Division - Equity Analyst

All right, guys. Good morning, and welcome, again, to the 2019 Jefferies Global Healthcare Conference. I'm Brian Tanquilut, I'm the health care services analyst here at Jefferies. And our next company is Chemed. They are the leading hospice provider in the country today. And joining us are the company's CEO, Kevin McNamara; and the CEO of VITAS hospice, President, VITAS hospice, Nick Westfall.

Questions & Answers

Brian Gil Tanquilut
Jefferies LLC, Research Division - Equity Analyst

So Kevin, I'll pass it on to you, if you don't mind just giving us like lay of the land, what's been going on at Chemed over the last year or few years since reimbursement change had happened a few years back. If you don't mind just walk us through all the stuff that's happened over that time period.

Kevin J. McNamara
Chemed Corporation - CEO, President & Director

I'd give a kind of basic landscape. As you mentioned that there was a reimbursement change

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot